grey market peptides retatrutide Retatrutide, an experimental weight-loss drug, has not been approved by the FDA. But, doctors and nurse practitioners in clinics across the country are prescribing it anyway, a CBS News investigation Explore the growing trend of

Wegovy, a drug that is approved for weight loss, is covered by just 1% of Marketplace prescription drug plans, compared to 82% of Marketplace prescription drug plans for Ozempic, which contains the same active ingredient as Wegovy (semaglutide) but is approved only for diabetes

Side effects are generally mild and manageable, usually involving only mild gastrointestinal symptoms that resolve quickly

Medication is prepared by state-licensed compounding pharmacies separate from both the platform and the clinicians

Cardiologists treating patients with atherosclerotic cardiovascular disease are increasingly initiating semaglutide as a cardiovascular risk modifier, adding an estimated 4.8 million new commercial GLP-1 patients annually

Below youll find clear answers to the most common concerns when it comes to stacking peptides

Orforgliprons application as a type 2 diabetes treatment will be filed with the FDA later this year